[Niraparib/abiraterone acetate (prostate cancer) – Addendum to Project A26-31]
Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen
Record ID 32018016148
German
Original Title:
Niraparib/Abirateronacetat (Prostatakarzinom) – Addendum zum Projekt A26-31
Details
Project Status:
Completed
URL for project:
https://www.iqwig.de/projekte/a26-98.html
Year Published:
2026
URL for published report:
https://www.iqwig.de/download/a26-98_niraparib-abriateronacetat_addendum-zum-projekt-a26-31_v1-0.pdf
English language abstract:
There is no English language summary available
Publication Type:
Full HTA
Country:
Germany
MeSH Terms
- Prostatic Neoplasms
- Abiraterone Acetate
- Antineoplastic Combined Chemotherapy Protocols
- Poly(ADP-ribose) Polymerase Inhibitors
Keywords
- Niraparib
- Abiraterone
- Prostatic Neoplasms
- Benefit Assessment
- NCT04497844
Contact
Organisation Name:
Institute for Quality and Efficiency in Health Care (IQWiG)
Contact Address:
IQWiG, Siegburger Str. 237, 50679 Cologne, GERMANY, Tel: +49(0)221-35685, Fax: +49(0)221-356851
Contact Email:
berichte@iqwig.de
Copyright:
Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.